UBS: Buy Dr. Reddy's Labs Q3FY11: waiting for fondaparinux; Target Rs 2000
"Fondaparinux and Allegra D-24 remain key near term triggers
We believe fondaparinux approval remains near term trigger for the stock. Partner facilities for the product have been inspected by US FDA and the co. remains hopeful of getting an approval in Q4FY11"
http://indiaer.blogspot.com/2011/01/ubs-buy-dr-reddys-labs-q3fy11-waiting.html
ubs - waiting for fondaparinux
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable